#news
-
News
TIF Thal e-Course: Testimonials from Online Learning Thalassaemia Patients
See what patients from various countries across the world who successfully took TIF‘s Thal e-Course, the ultimate self-paced, interactive, online Εducational Course for individuals with thalassaemia and their families, have to say…
Read More » -
News
TIF Launches Online Petition to Promote ”Equitable Access to Safe and Adequate Blood”
A few days before the celebration of the World Blood Donor Day 2020, TIF has launched an online petition, co-signed by the European Blood Alliance (EBA), to promote ”Equitable Access…
Read More » -
Clinical News
FDA Grants Orphan Drug Designation to Mitapivat for Treatment of Thalassaemia
Agios Pharmaceuticals Inc. announced that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation to the company’s first-in-class pyruvate kinase-R (PKR) activator Mitapivat for the treatment of…
Read More » -
News
FDA Grants RMAT Designation to CTX-001™ for the Treatment of Severe TDT β-Thalassaemia & SCD
CRISPR Therapeutics and Vertex Pharmaceuticals announced that the U.S. Food and Drug Administration (FDA) granted Regenerative Medicine Advanced Therapy (RMAT) designation to CTX-001, an investigational, autologous, Gene Editing hematopoietic stem cell therapy, for the treatment of severe Transfusion-Dependent β-Thalassaemia (TDT) and Sickle…
Read More » -
TIF News
TIF’s Latest Guide for the COVID-19 Pandemic is Going Public on the International Thalassaemia Day 2020
As the online celebrations for the International Thalassaemia Day 2020 are at their peak, TIF decided to publish today as a gift to its worldwide patient communities a new guide entitled ”COVID-19…
Read More » -
Clinical News
Reblozyl (luspatercept-aamt) Receives Positive CHMP Opinion for the Treatment of Adults with β-Thalassaemia
On 30 April 2020, the Committee for Medicinal Products for Human Use (CHMP) adopted a positive opinion, recommending the granting of a marketing authorisation for the medicinal product REBLOZYL, intended for the treatment of adults…
Read More » -
News
WORLD HEALTH DAY: Honouring the work of nurses and midwives – 7 April 2020
Nurses and other health workers are at the frontlines of COVID-19 response, putting their own health at risk to protect the broader community. This World Health Day, the World Health Organisation…
Read More » -
News
AABB’s Develops Toolkit with Information Regarding Blood Donation & the COVID-19 Outbreak
As the new coronavirus continues to spread affecting an increasing number of countries around the globe and in response to FDA’s Important Information for Blood Establishments Regarding the Novel Coronavirus…
Read More » -
News
‘FAiTh – Fight Against Thalassemia Association’ presents its activities for January 2020
The ‘FAiTh – Fight Against Thalassemia’ group, a longtime member of TIF operating in Pakistan, is dedicated to support, serve and love people with thalassaemia and their families, intending…
Read More » -
Member News
Iranian Blood Transfusion Organization (IBTO) Newsletter – November 2019
The latest issue from the Iranian Blood Transfusion Organization’s (IBTO) newsletter is now available on TIF’s website!
Read More »